The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Incyte; MSD; Roche
 
Honoraria - Amgen; Bristol-Myers Squibb; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
Horizon: An ambispective study of 663 patients who initiated pembrolizumab for advanced melanoma within the French early access program.
 
Nicolas Meyer
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Expert Testimony - Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Laurent Mortier
No Relationships to Disclose
 
Caroline Dutriaux
Honoraria - Bristol-Myers Squibb; MSD; Roche
 
Marie Thérèse Leccia
No Relationships to Disclose
 
Brigitte Dreno
No Relationships to Disclose
 
Evelyne Boos
No Relationships to Disclose
 
Catherine Hunault
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Lynda Benmahammed
Employment - MSD
 
Philippe Saiag
Honoraria - Bristol-Myers Squibb; Incyte; MSD; Novartis; Roche